Based on the key measurements obtained from HealthEquity's financial statements, HealthEquity is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in April. At this time, HealthEquity's Intangible Assets are fairly stable compared to the past year. Property Plant Equipment is likely to rise to about 83.7 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 79 M in 2025. Key indicators impacting HealthEquity's financial strength include:
The financial analysis of HealthEquity is a critical element in measuring its lifeblood. Investors should not minimize HealthEquity's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income
52.65 Million
HealthEquity
Select Account or Indicator
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change To Inventory
Change In Cash
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Change To Account Receivables
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Change To Netincome
Change To Liabilities
Sale Purchase Of Stock
Investments
Change Receivables
Total Cashflows From Investing Activities
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Change To Operating Activities
Other Cashflows From Investing Activities
Net Borrowings
Issuance Of Capital Stock
Total Assets
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Other Liab
Accounts Payable
Cash
Other Assets
Good Will
Common Stock Shares Outstanding
Short Term Investments
Inventory
Other Current Assets
Total Liab
Intangible Assets
Common Stock
Property Plant Equipment
Property Plant And Equipment Net
Net Debt
Retained Earnings
Non Current Assets Total
Cash And Short Term Investments
Net Receivables
Common Stock Total Equity
Liabilities And Stockholders Equity
Non Current Liabilities Total
Other Stockholder Equity
Property Plant And Equipment Gross
Total Current Assets
Accumulated Other Comprehensive Income
Net Tangible Assets
Non Currrent Assets Other
Long Term Debt
Retained Earnings Total Equity
Deferred Long Term Liab
Capital Surpluse
Non Current Liabilities Other
Net Invested Capital
Net Working Capital
Capital Stock
Short Long Term Debt Total
Capital Lease Obligations
Short Long Term Debt
Short Term Debt
Depreciation And Amortization
Interest Expense
Selling General Administrative
Selling And Marketing Expenses
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Research Development
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Net Income Applicable To Common Shares
Income Tax Expense
Net Income From Continuing Ops
Non Operating Income Net Other
Tax Provision
Reconciled Depreciation
Net Interest Income
Interest Income
Probability Of Bankruptcy
Understanding current and past HealthEquity Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of HealthEquity's financial statements are interrelated, with each one affecting the others. For example, an increase in HealthEquity's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in HealthEquity's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of HealthEquity. Check HealthEquity's Beneish M Score to see the likelihood of HealthEquity's management manipulating its earnings.
HealthEquity Stock Summary
HealthEquity competes with Ollies Bargain, Appfolio, Grand Canyon, and Globus Medical. HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company was incorporated in 2002 and is headquartered in Draper, Utah. Healthequity operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 3688 people.
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
Cash flow analysis captures how much money flows into and out of HealthEquity. It measures of how well HealthEquity is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money HealthEquity brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money HealthEquity had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what HealthEquity has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
Comparative valuation techniques use various fundamental indicators to help in determining HealthEquity's current stock value. Our valuation model uses many indicators to compare HealthEquity value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across HealthEquity competition to find correlations between indicators driving HealthEquity's intrinsic value. More Info.
HealthEquity is one of the top stocks in return on equity category among its peers. It is rated # 2 in return on asset category among its peers reporting about 0.81 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for HealthEquity is roughly 1.24 . At this time, HealthEquity's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the HealthEquity's earnings, one of the primary drivers of an investment's value.
HealthEquity Systematic Risk
HealthEquity's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. HealthEquity volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on HealthEquity correlated with the market. If Beta is less than 0 HealthEquity generally moves in the opposite direction as compared to the market. If HealthEquity Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one HealthEquity is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of HealthEquity is generally in the same direction as the market. If Beta > 1 HealthEquity moves generally in the same direction as, but more than the movement of the benchmark.
HealthEquity Thematic Clasifications
HealthEquity is part of Tech Growth investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Large and mid-sized technology companies, funds, and technology-based ETFs that are considered growing. Instruments that are typically traded at high earnings multiples compared to their competitors and other sectors and have been known to drive market cycles frequently
This theme covers Large and mid-sized technology companies, funds, and technology-based ETFs that are considered growing. Instruments that are typically traded at high earnings multiples compared to their competitors and other sectors and have been known to drive market cycles frequently. Get More Thematic Ideas
Today, most investors in HealthEquity Stock are looking for potential investment opportunities by analyzing not only static indicators but also various HealthEquity's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of HealthEquity growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of HealthEquity help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of HealthEquity. We use our internally-developed statistical techniques to arrive at the intrinsic value of HealthEquity based on widely used predictive technical indicators. In general, we focus on analyzing HealthEquity Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build HealthEquity's daily price indicators and compare them against related drivers.
When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.